CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 30.57
  • +0.40+1.33%
Market Closed May 17 15:00 CST
4.89BMarket Cap29.39P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
-25.99%156.19M
0.14%809.78M
Operating revenue
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
-25.99%156.19M
0.14%809.78M
Other operating revenue
----
-85.60%2.26M
----
-88.02%1.89M
----
-86.57%15.68M
----
-81.65%15.76M
----
--116.76M
Total operating cost
11.98%150.67M
6.36%773.68M
8.37%548.85M
9.21%347.35M
5.51%134.55M
8.14%727.45M
9.78%506.47M
-11.94%318.06M
-10.42%127.53M
3.25%672.67M
Operating cost
27.67%22.46M
-19.90%101.05M
-14.33%73.22M
-12.44%47.49M
-17.26%17.59M
19.29%126.16M
9.24%85.48M
-1.26%54.23M
23.15%21.26M
78.50%105.76M
Operating tax surcharges
-4.88%1.33M
-9.19%5.9M
-7.54%4.64M
-15.34%3.03M
-12.96%1.4M
-25.24%6.5M
-26.06%5.01M
-31.37%3.58M
-46.11%1.61M
-26.46%8.69M
Operating expense
19.72%90.45M
11.68%472.59M
13.51%344.49M
17.42%219.53M
5.61%75.55M
8.14%423.15M
14.95%303.49M
-13.59%186.97M
-23.34%71.54M
-17.30%391.28M
Administration expense
26.78%26.16M
7.76%110.7M
-4.86%70.32M
-3.12%46.3M
-0.16%20.64M
16.66%102.72M
15.93%73.91M
11.83%47.79M
15.12%20.67M
41.20%88.06M
Financial expense
43.70%-1.05M
35.84%-11.46M
31.54%-11.03M
8.53%-9.29M
56.33%-1.87M
23.65%-17.86M
10.01%-16.12M
16.55%-10.15M
18.22%-4.28M
51.44%-23.39M
-Interest expense (Financial expense)
314.84%1.23M
221.89%2.78M
117.45%1.23M
55.42%615.48K
42.45%297.32K
-38.66%864.06K
-46.15%565.22K
-50.95%396.02K
-41.71%208.73K
236.64%1.41M
-Interest Income (Financial expense)
9.92%-2.92M
25.63%-13.77M
31.38%-10.02M
29.82%-6.87M
28.90%-3.24M
24.65%-18.52M
22.75%-14.59M
22.72%-9.79M
24.83%-4.56M
49.48%-24.57M
Research and development
-46.72%11.32M
9.38%94.91M
22.87%67.22M
13.01%40.29M
26.98%21.24M
-15.15%86.78M
-17.66%54.71M
-34.08%35.65M
4.11%16.73M
9.84%102.27M
Credit Impairment Loss
-100.30%-4.22K
-232.40%-7.25M
-317.39%-2.09M
-117.11%-80.17K
-31.28%1.39M
-578.90%-2.18M
161.26%960.72K
127.83%468.43K
154.59%2.02M
-36.39%455.58K
Asset Impairment Loss
----
-161.49%-11.91M
----
----
----
---4.56M
----
----
----
----
Other net revenue
-67.86%1.7M
-313.40%-3.04M
-59.93%17.34M
-60.60%17.15M
-79.49%5.28M
-97.41%1.43M
87.07%43.26M
141.92%43.54M
480.22%25.74M
3.93%55.18M
Fair value change income
100.59%1.05M
86.81%-866.8K
-1,337.16%-1.64M
---1.74M
-20.09%522.45K
-115.76%-6.57M
--132.62K
----
-59.47%653.82K
2,956.90%41.68M
Invest income
-138.89%-536.93K
616.30%5.56M
-61.86%10.78M
-65.16%10.16M
-93.57%1.38M
82.17%-1.08M
326.71%28.27M
315.12%29.18M
11,104.37%21.49M
-153.34%-6.04M
-Including: Investment income associates
-91.44%-657.01K
7.20%-8.79M
-109.38%-1.9M
-104.77%-1.01M
-101.60%-343.2K
-225.96%-9.47M
1,502.43%20.22M
2,132.89%21.12M
11,087.81%21.46M
-762.54%-2.91M
Asset deal income
----
---8.23K
----
----
----
----
----
----
----
--18.38K
Other revenue
-40.15%1.19M
-27.69%11.43M
-26.02%10.28M
-36.61%8.81M
25.91%1.99M
-17.07%15.81M
-23.09%13.9M
9.82%13.9M
-29.07%1.58M
-51.97%19.07M
Operating profit
40.27%50.26M
1.83%143.28M
51.09%188.53M
24.28%120.64M
-34.14%35.83M
-26.83%140.7M
-21.22%124.78M
-13.63%97.07M
-25.60%54.41M
-8.53%192.29M
Add:Non operating Income
-99.11%444.93
-48.38%261.5K
-49.07%257.56K
1,201.68%57.38K
2,292.92%50.19K
-87.64%506.62K
9,282.50%505.72K
203.60%4.41K
188.88%2.1K
106,223.26%4.1M
Less:Non operating expense
-100.00%26.66
2,229.06%20.81M
58.03%1.01M
238.14%805.78K
1,194.09%802.24K
-88.14%893.56K
19.52%638.3K
1,705.46%238.3K
404.73%61.99K
242.00%7.54M
Total profit
43.28%50.26M
-12.53%122.73M
50.64%187.77M
23.81%119.89M
-35.45%35.08M
-25.70%140.32M
-21.04%124.65M
-13.82%96.83M
-25.67%54.35M
-9.21%188.86M
Less:Income tax cost
-34.48%3.42M
-494.83%-64.84M
146.32%24.94M
135.22%16.52M
33.49%5.22M
-23.32%16.42M
-35.07%10.12M
-43.12%7.02M
-55.19%3.91M
-13.19%21.42M
Net profit
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
-21.67%50.44M
-8.68%167.44M
Net profit from continuing operation
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
-21.67%50.44M
-8.68%167.44M
Less:Minority Profit
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
114.69%10.85M
2,606,814.58%7.77M
36,393,936.18%4M
512,907.98%19.46M
Net profit of parent company owners
62.28%41.65M
48.24%150.45M
43.37%148.63M
13.23%92.89M
-44.72%25.67M
-31.42%101.49M
-24.45%103.67M
-17.98%82.04M
-27.89%46.44M
-19.29%147.99M
Earning per share
Basic earning per share
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
-26.83%0.3
-18.26%0.94
Diluted earning per share
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
-26.83%0.3
-18.26%0.94
Other composite income
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.78%-57.58M
72.80%-41.31M
85.53%-19.14M
-166.62%-171.46M
Other composite income of parent company owners
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.16%-57.58M
72.80%-41.31M
85.53%-19.14M
-166.62%-171.46M
Total composite income
-23.60%84.95M
95.43%193.87M
266.26%208.57M
309.68%198.7M
255.34%111.2M
2,567.29%99.2M
235.09%56.94M
193.52%48.5M
146.10%31.3M
-100.91%-4.02M
Total composite income of parent company owners
-25.46%79.76M
104.11%156.75M
321.70%194.36M
362.13%188.22M
292.09%107.01M
427.13%76.8M
205.58%46.09M
178.53%40.73M
140.20%27.29M
-105.33%-23.48M
Total composite income of minority owners
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
623.40%10.85M
2,606,814.58%7.77M
36,393,936.18%4M
512,907.98%19.46M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion with explanatory notes
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M-25.99%156.19M0.14%809.78M
Operating revenue 20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M-25.99%156.19M0.14%809.78M
Other operating revenue -----85.60%2.26M-----88.02%1.89M-----86.57%15.68M-----81.65%15.76M------116.76M
Total operating cost 11.98%150.67M6.36%773.68M8.37%548.85M9.21%347.35M5.51%134.55M8.14%727.45M9.78%506.47M-11.94%318.06M-10.42%127.53M3.25%672.67M
Operating cost 27.67%22.46M-19.90%101.05M-14.33%73.22M-12.44%47.49M-17.26%17.59M19.29%126.16M9.24%85.48M-1.26%54.23M23.15%21.26M78.50%105.76M
Operating tax surcharges -4.88%1.33M-9.19%5.9M-7.54%4.64M-15.34%3.03M-12.96%1.4M-25.24%6.5M-26.06%5.01M-31.37%3.58M-46.11%1.61M-26.46%8.69M
Operating expense 19.72%90.45M11.68%472.59M13.51%344.49M17.42%219.53M5.61%75.55M8.14%423.15M14.95%303.49M-13.59%186.97M-23.34%71.54M-17.30%391.28M
Administration expense 26.78%26.16M7.76%110.7M-4.86%70.32M-3.12%46.3M-0.16%20.64M16.66%102.72M15.93%73.91M11.83%47.79M15.12%20.67M41.20%88.06M
Financial expense 43.70%-1.05M35.84%-11.46M31.54%-11.03M8.53%-9.29M56.33%-1.87M23.65%-17.86M10.01%-16.12M16.55%-10.15M18.22%-4.28M51.44%-23.39M
-Interest expense (Financial expense) 314.84%1.23M221.89%2.78M117.45%1.23M55.42%615.48K42.45%297.32K-38.66%864.06K-46.15%565.22K-50.95%396.02K-41.71%208.73K236.64%1.41M
-Interest Income (Financial expense) 9.92%-2.92M25.63%-13.77M31.38%-10.02M29.82%-6.87M28.90%-3.24M24.65%-18.52M22.75%-14.59M22.72%-9.79M24.83%-4.56M49.48%-24.57M
Research and development -46.72%11.32M9.38%94.91M22.87%67.22M13.01%40.29M26.98%21.24M-15.15%86.78M-17.66%54.71M-34.08%35.65M4.11%16.73M9.84%102.27M
Credit Impairment Loss -100.30%-4.22K-232.40%-7.25M-317.39%-2.09M-117.11%-80.17K-31.28%1.39M-578.90%-2.18M161.26%960.72K127.83%468.43K154.59%2.02M-36.39%455.58K
Asset Impairment Loss -----161.49%-11.91M---------------4.56M----------------
Other net revenue -67.86%1.7M-313.40%-3.04M-59.93%17.34M-60.60%17.15M-79.49%5.28M-97.41%1.43M87.07%43.26M141.92%43.54M480.22%25.74M3.93%55.18M
Fair value change income 100.59%1.05M86.81%-866.8K-1,337.16%-1.64M---1.74M-20.09%522.45K-115.76%-6.57M--132.62K-----59.47%653.82K2,956.90%41.68M
Invest income -138.89%-536.93K616.30%5.56M-61.86%10.78M-65.16%10.16M-93.57%1.38M82.17%-1.08M326.71%28.27M315.12%29.18M11,104.37%21.49M-153.34%-6.04M
-Including: Investment income associates -91.44%-657.01K7.20%-8.79M-109.38%-1.9M-104.77%-1.01M-101.60%-343.2K-225.96%-9.47M1,502.43%20.22M2,132.89%21.12M11,087.81%21.46M-762.54%-2.91M
Asset deal income -------8.23K------------------------------18.38K
Other revenue -40.15%1.19M-27.69%11.43M-26.02%10.28M-36.61%8.81M25.91%1.99M-17.07%15.81M-23.09%13.9M9.82%13.9M-29.07%1.58M-51.97%19.07M
Operating profit 40.27%50.26M1.83%143.28M51.09%188.53M24.28%120.64M-34.14%35.83M-26.83%140.7M-21.22%124.78M-13.63%97.07M-25.60%54.41M-8.53%192.29M
Add:Non operating Income -99.11%444.93-48.38%261.5K-49.07%257.56K1,201.68%57.38K2,292.92%50.19K-87.64%506.62K9,282.50%505.72K203.60%4.41K188.88%2.1K106,223.26%4.1M
Less:Non operating expense -100.00%26.662,229.06%20.81M58.03%1.01M238.14%805.78K1,194.09%802.24K-88.14%893.56K19.52%638.3K1,705.46%238.3K404.73%61.99K242.00%7.54M
Total profit 43.28%50.26M-12.53%122.73M50.64%187.77M23.81%119.89M-35.45%35.08M-25.70%140.32M-21.04%124.65M-13.82%96.83M-25.67%54.35M-9.21%188.86M
Less:Income tax cost -34.48%3.42M-494.83%-64.84M146.32%24.94M135.22%16.52M33.49%5.22M-23.32%16.42M-35.07%10.12M-43.12%7.02M-55.19%3.91M-13.19%21.42M
Net profit 56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M-21.67%50.44M-8.68%167.44M
Net profit from continuing operation 56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M-21.67%50.44M-8.68%167.44M
Less:Minority Profit 23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M114.69%10.85M2,606,814.58%7.77M36,393,936.18%4M512,907.98%19.46M
Net profit of parent company owners 62.28%41.65M48.24%150.45M43.37%148.63M13.23%92.89M-44.72%25.67M-31.42%101.49M-24.45%103.67M-17.98%82.04M-27.89%46.44M-19.29%147.99M
Earning per share
Basic earning per share 68.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52-26.83%0.3-18.26%0.94
Diluted earning per share 68.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52-26.83%0.3-18.26%0.94
Other composite income -53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.78%-57.58M72.80%-41.31M85.53%-19.14M-166.62%-171.46M
Other composite income of parent company owners -53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.16%-57.58M72.80%-41.31M85.53%-19.14M-166.62%-171.46M
Total composite income -23.60%84.95M95.43%193.87M266.26%208.57M309.68%198.7M255.34%111.2M2,567.29%99.2M235.09%56.94M193.52%48.5M146.10%31.3M-100.91%-4.02M
Total composite income of parent company owners -25.46%79.76M104.11%156.75M321.70%194.36M362.13%188.22M292.09%107.01M427.13%76.8M205.58%46.09M178.53%40.73M140.20%27.29M-105.33%-23.48M
Total composite income of minority owners 23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M623.40%10.85M2,606,814.58%7.77M36,393,936.18%4M512,907.98%19.46M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion with explanatory notes------Unqualified opinion------Unqualified opinion
Auditor --Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg